# TESTO-TRIAL: Use of Testosterone in Critically Ill Patients

> **NCT06592144** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Leticia Maria Defendi Barboza Marson** · enrollment: 94 (estimated)

## Conditions studied

- Weaning Failure
- Muscle Weakness
- Mechanical Ventilation Complication
- ICU Acquired Weakness
- Mobility Limitation

## Interventions

- **DRUG:** Testosterone cypionate (200mg/3ml)
- **OTHER:** Sesame oil (3ml)

## Key facts

- **NCT ID:** NCT06592144
- **Lead sponsor:** Leticia Maria Defendi Barboza Marson
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-09-09
- **Primary completion:** 2026-08-02
- **Final completion:** 2026-11-02
- **Target enrollment:** 94 (ESTIMATED)
- **Last updated:** 2024-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06592144

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06592144, "TESTO-TRIAL: Use of Testosterone in Critically Ill Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06592144. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*